
A unique financial scheme that was launched Bengal on Wednesday will allow heart patients in the state to opt for advanced treatments at an affordable cost.
Kolkata's Belle Vue Clinic has partnered with India Medtronic to extend its scheme of equated monthly installment (EMI) under the Healthy Heart For All (HHFA) initiative.
Advertisement
"We have started the EMI scheme for cardiac patients as the major problem in India is affordability," said Munish Sehegal, business model innovator of India Medtronic.
Over three million deaths result due to heart diseases in India and the mortality rate goes up due to affordability and unawareness.
HHFA provides loan assistance at easy installments for implants, pacemakers, stents, implantable cardiovert defibrillators and triple chambers pacemakers.
The scheme benefits patients covered under health Insurance and also patients who have no health insurance or cannot get easy loans.
According to estimates, cardiac ailments claim 17.3 millions lives all over the world annually.
Source: IANS
HHFA provides loan assistance at easy installments for implants, pacemakers, stents, implantable cardiovert defibrillators and triple chambers pacemakers.
The scheme benefits patients covered under health Insurance and also patients who have no health insurance or cannot get easy loans.
According to estimates, cardiac ailments claim 17.3 millions lives all over the world annually.
Source: IANS
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Indian Health News

The Rs 1,500 crore 'Chief Minister Health at Doorstep' program aims to cut expenses and conduct blood tests for those aged 60+.

In Bihar, a mysterious ailment named "Langda fever" by locals has emerged, causing patients to recover from fever but struggle to walk due to joint pain.

Upon analyzing the years of life lost due to cancer, the team discovered that the four avoidable risk factors led to an annual loss of over 30 million years of life.

Over the past three to four weeks in Delhi, there has been an increase of 20-30% in patients with recurring cough and upper respiratory tract infections.

Premature infants with gastrointestinal complications and metabolic disorders stand to benefit the most from this Lactarium initiative.